Staff Profile
Dr Andrew Knight
Senior Lecturer
- Address: School of Biomedical, Nutritional and Sport Sciences
M1034 1st Floor Catherine Cookson Building
Faculty of Medical Sciences
Newcastle University
Framlington Place
Newcastle upon Tyne
NE2 4HH. UK
Qualifications
Senior Fellowship of the HEA (2016)
Professional Certificate in University Teaching (Stages 1/2). University of Edinburgh (2003)
Ph.D. (Immunogenetics); MRC Clinical Research Centre, Harrow. Middx. 1993
Grad. I. Biol. (Biochemistry); North East Surrey College of Technology, Ewell. Surrey. 1987
Previous Positions
2003-2005
Wellcome Trust Teaching Fellow.
Institute for Immunology and Infection Research (IIIR), School of Biological Sciences, Ashworth Laboratories, University of Edinburgh, Edinburgh
1999-2003
Wellcome Trust Career Development Fellow
Institute for Immunology and Infection Research (IIIR), School of Biological Sciences, Ashworth Laboratories, University of Edinburgh, Edinburgh
1994–1999
Senior Post-Doctoral Research Assistant, Department of Biochemistry, Medical Sciences Institute, University of Dundee, Dundee
1988-1993
Scientific Officer (part-time Ph.D. student) Transplantation Biology Section, Clinical Research Centre, Harrow, Middlesex
1986
Junior Research Technician, Ludwig Institute for Cancer Research, Haddow Laboratories, Sutton, Surrey
Memberships
British Society For Immunology (BSI)
Secretary Immunology North East (BSI regional group) (2006-2014)
Treasurer Immunology North East (2017-
Previous research interests
For the initiation of the CD4+ T cell response, native protein antigens (Ag.) must be captured, intra-cellularly processed, complexed with molecules encoded by the major histocompatibility complex (MHC) class II region and re-expressed on the cell surface of antigen presenting cells (APC).
The use of specific Ag. receptors expressed on the surface of APC has been shown to enhance this process by several orders of magnitude. As well as producing antibodies, B cells function as APC and express several surface Ag. receptors.
My interest lies in these specialized antigen receptors and is aimed primarily at understanding the role of B cells as APC in mediating immunity to invading pathogens. I am also interested in situations where B cell APC function has apparently become de-regulated leading to the development of autoimmunity (in collaboration with Jeremy Palmer and John Robinson (Musculoskeletal Research group) as well as a possible role for B cells in tumour surveillance (in collaboration with John Kirby).
Postgraduate Supervision
1. Faculty of Medicine/Institute of Cellular Medicine-funded PhD studentship: "Biliary autoantigen acquisition and presentation by B lymphocytes." 2010-13. The University of Newcastle upon Tyne; Co-supervisor
2. Arthritis Research UK-funded PhD studentship: "The role of B cells as antigen presenting cells in a model of Rheumatoid Arthritis." 2009-12. The University of Newcastle upon Tyne; Main supervisor
3. Self-funded Studentship. "Generation and Testing of a novel multimeric C3d based adjuvant." 2008-2012; The University of Newcastle upon Tyne; Co-supervisor
4. Arthritis Research UK -funded Ph.D. Studentship "The Role of B Lymphocytes in Processing and Presentation of the Candidate Joint Autoantigen, Aggrecan in a Model of Rheumatiod Arthritis." 2006-2009. The University of Newcastle upon Tyne; Main supervisor
5. Royal Victoria Infirmary (RVI) Breast Clinic Appeal-funded Ph.D. Studentship.
"Understanding the mechanisms involved in the immuno-recognition of breast cancer cells" 2006-2009. The University of Newcastle upon Tyne; Main supervisor
6. BBSRC Case Studentship. "The Novel C3d Co-presentation Approach to Developing a Vaccine Targeting PfEMP-1." 2001-2004. The University of Edinburgh/Adprotech Ltd. ; Co-supervisor
7. Wellcome Trust 4-Year Ph.D. Programme. "Presentation of native antigen to B cells." 2000-2004. The University of Edinburgh; Main supervisor
8. Self-funded Studentship. “Host and Parasite Genes Involved in Immunity to Plasmodium chabaudi.” 2000-2003. The University of Edinburgh; Co-supervisor.
Keywords
B cells, antigen processing and presentation, complement receptors, autoimmunity, cancer immunology.
Undergraduate
Biomedical and Biomolecular Sciences (BSc Honours programme)
Stage 3 module co-module leader "Research Project'
Biomedical Sciences BSc Honours
Stage 3 module leader/lecturer "Immunology of Health and Disease"
Stage 3 lecturer "Medical Biotechnology"
Stage 2 module leader/lecturer "Cell and Molecular Biology of the Immune System"
Stage 2 lecturer "Cell Biology and Disease'
Stage 2 lecturer "Clinical Immunology and Viral pathogens"
Biochemistry BSc Honours
Stage 3 lecturer "Applied Biochemistry"
SBNS personal tutor
SBNS TEL representative
Staff Development (2013-2019)
Faculty of Medical Sciences Faculty Programme Liason Officer (FPLO) for the Certificate in Advanced Studies in Academic Practice (CASAP) (2013-2019)
AdvanceHE (formerly Higher Education Academy) Senior Fellow (2016)
Administration
School of BNS, co-chair of Phase II Biomedical Sciences Curriculum Committee
External examiner
University of Edinburgh, School of Biological Sciences: 3rd/4th year Immunology course (2022-
University of Glasgow, School of Life Sciences: 2nd year BSc. courses (2020-2024)
University of Liverpool: BSc. Genetics and Molecular Biology (2015-2019)
PhD assessment panel
-
Articles
- Hunter JE, Campbell AE, Butterworth JA, Sellier H, Hannaway NL, Luli S, Floudas A, Kenneth NS, Moore AJ, Brownridge PJ, Thomas HD, Coxhead J, Taylor L, Leary P, Hasoon MSR, Knight AM, Garrett MD, Collins I, Eyers CE, Perkins ND. Mutation of the RelA(p65) Thr505 phosphosite disrupts the DNA replication stress response leading to CHK1 inhibitor resistance. Biochemical Journal 2022, 479(19), 2087-2113.
- He Y-G, Pappworth IY, Rossbach A, Paulin J, Mavimba T, Hayes C, Kulik L, Holers VM, Knight AM, Marchbank KJ. A novel C3d-containing oligomeric vaccine provides insight into the viability of testing human C3d-based vaccines in mice. Immunobiology 2018, 223(1), 125-134.
- Knight AM. B-cell acquisition of antigen: Sensing the surface. European Journal of Immunology 2015, 45(6), 1600-1604.
- Ciechomska M, Wilson CL, Floudas A, Hui W, Rowan AD, van Eden W, Robinson JH, Knight AM. Antigen-specific B lymphocytes acquire proteoglycan aggrecan from cartilage extracellular matrix resulting in antigen presentation and CD4+ T-cell activation. Immunology 2014, 141(1), 70-78.
- Wilson CL, Hine DW, Pradipta A, Pearson JP, van Eden W, Robinson JH, Knight AM. Presentation of the candidate rheumatoid arthritis autoantigen aggrecan by antigen-specific B cells induces enhanced CD4+T helper type 1 subset differentiation. Immunology 2012, 135(4), 344-354.
- Ciechomska M, Lennard TWJ, Kirby JA, Knight AM. B lymphocytes acquire and present intracellular antigens that have relocated to the surface of apoptotic target cells. European Journal of Immunology 2011, 41(7), 1850-1861.
- Knight AM. Regulated release of B cell-derived exosomes: Do differences in exosome release provide insight into different APC function for B cells and DC?. European Journal of Immunology 2008, 38(5), 1186-1189.
- Hoefer MM, Aichem A, Knight AM, Illges H. Modulation of murine complement receptor type 2 (CR2/CD21) ectodomain shedding by its cytoplasmic domain. Molecular Immunology 2008, 45(8), 2127-2137.
- Brown SL, Barrault DV, Phythian-Adams A, Knight AM. Lack of induced co-stimulation as a result of complement receptor 2 (CR2) ligation on mouse splenic B cells. International Immunology 2006, 18(1), 69-78.
- Barrault DV, Steward M, Cox VF, Smith RAG, Knight AM. Efficient production of complement (C3d)3 fusion proteins using the baculovirus expression vector system. Journal of Immunological Methods 2005, 304(1-2), 158-173.
- Brooks K, Knight AM. Lowering the affinity between antigen and the B cell receptor can enhance antigen presentation. European Journal of Immunology 2004, 34(3), 837-843.
- Barrault DV, Knight AM. Distinct Sequences in the Cytoplasmic Domain of Complement Receptor 2 Are Involved in Antigen Internalization and Presentation. Journal of Immunology 2004, 172(6), 3509-3517.
- A. M. Knight,J. M. Lucocq,A. R. Prescott,S. Ponnambalam,C. Watts. Antigen endocytosis and presentation mediated by human membrane IgG1 in the absence of the Ig(alpha)/Ig(beta) dimer. Embo J 1997, 16(13), 3842-50.
- E. Simpson,P. J. Dyson,A. M. Knight,P. J. Robinson,J. I. Elliott,D. M. Altmann. T-cell receptor repertoire selection by mouse mammary tumor viruses and MHC molecules. Immunol Rev 1993, 131, 93-115.
- G. A. Fowlis,S. Adelman,A. M. Knight,E. Simpson. PCR-analyzed microsatellites of the mouse genome--additional polymorphisms among ten inbred mouse strains. Mamm Genome 1992, 3(4), 192-6.
- P. J. Dyson,C. de Smet,A. M. Knight,D. Simon-Chazottes,J. L. Guenet,T. Boon. Mapping of the genes encoding tum- transplantation antigens P91A, P35B, and P198. Immunogenetics 1992, 35(5), 316-23.
- M. McDuffie,D. Schweiger,B. Reitz,A. Ostrowska,A. M. Knight,P. J. Dyson. I-E-independent deletion of V beta 17a+ T cells by Mtv-3 from the nonobese diabetic mouse. J Immunol 1992, 148(7), 2097-102.
- K. Tomonari,S. Fairchild,O. A. Rosenwasser,P. J. Robinson,A. M. Knight,P. J. Dyson. Endogenous ligands selecting T cells expressing particular V beta elements. Int Rev Immunol 1992, 8(4), 289-309.
- A. M. Knight,G. B. Harrison,R. J. Pease,P. J. Robinson,P. J. Dyson. Biochemical analysis of the mouse mammary tumor virus long terminal repeat product. Evidence for the molecular structure of an endogenous superantigen. Eur J Immunol 1992, 22(3), 879-82.
- J. A. Todd,T. J. Aitman,R. J. Cornall,S. Ghosh,J. R. Hall,C. M. Hearne,A. M. Knight,J. M. Love,M. A. McAleer,J. B. Prins,et al. Genetic analysis of autoimmune type 1 diabetes mellitus in mice. Nature 1991, 351(6327), 542-7.
- P. J. Dyson,A. M. Knight,S. Fairchild,E. Simpson,K. Tomonari. Genes encoding ligands for deletion of V beta 11 T cells cosegregate with mammary tumour virus genomes. Nature 1991, 349(6309), 531-2.
- C. M. Hearne,M. A. McAleer,J. M. Love,T. J. Aitman,R. J. Cornall,S. Ghosh,A. M. Knight,J. B. Prins,J. A. Todd. Additional microsatellite markers for mouse genome mapping. Mamm Genome 1991, 1(4), 273-82.
- J. M. Love,A. M. Knight,M. A. McAleer,J. A. Todd. Towards construction of a high resolution map of the mouse genome using PCR-analysed microsatellites. Nucleic Acids Res 1990, 18(14), 4123-30.
- A. M. Knight,P. J. Dyson. Detection of DNA polymorphisms between two inbred mouse strains-- limitations of restriction fragment length polymorphisms (RFLPs). Mol Cell Probes 1990, 4(6), 497-504.
-
Conference Proceedings (inc. Abstracts)
- Floudas A, Griffiths L, Jones D, Knight AM, Palmer JM. Altered B cell populations and cytokine production in primary biliary cirrhosis. In: BSI Congress 2013: Annual Congress of the British-Society-for-Immunology. 2013, Liverpool, England: Wiley-Blackwell Publishing Ltd.